.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster presentation
P-III-1020

Proteomic characterization of acquired PARP inhibitor resistance in high-grade serous ovarian cancer

Appointment

Date: Wed, Oct 23

Time: 13:00 – 13:00

Talk time: 0 Min.

Discussion time: 0 Min.

Location / Stream:

Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)

Session

Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)

Topic

Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)

Authors

Jolene Duda (Minneapolis, MN / US), Xiaonan Hou (Rochester, NY / US), Ann Oberg (Rochester, NY / US), Krista Goergen (Rochester, NY / US), John Weroha (Rochester, NY / US), Stefani Thomas (Minneapolis, MN / US)